37th Hematology Tutorial on Anemia of Chronic Disease and Myelodysplastic Syndromes (Prague)
Dates: November 13-14, 2015
Location: Prague, Czech Republic
Venue: Angelo Hotel Prague’ VI Hotels & Resorts Czech Republic
Chairs: B Bain (UK), M D Cappellini (IT), G Weiss (AT)
Angelo Hotel Prague’ VI Hotels & Resorts Czech Republic
150 00 Praha 5
Goal of the Meeting
This tutorial focuses on pathogenesis, diagnosis and new approaches to treatment for clinical hematologists in the field of anemia of chronic diseases and myelodysplastic/myeloproliferative disorders.
Learning Objectives Anemia of Chronic Disease: After participating in this Tutorial, participants should be able to:
- Review new insights in pathogenesis of ACD including changes in iron metabolism and regulatory function of hepcidin.
- Review a list of appropriate laboratory investigations with special regard to diagnosis of iron deficiency in cases with combination of different pathogenetic mechanisms (eg. inflammatory bowell disease).
- Review new therapeutic options for patients with ACD (role of iron and EPO administration, new drugs eg. minihepcidins, hepcidin antagonists).
Learning Objectives Mixed Myelodysplastic Syndromes: After participating in this Tutorial, participants should be able to:
- Review diagnostic criteria and differential diagnosis of MDS/MPS with special regard to MDS with fibrosis.
- Review therapeutic options for patients with mixed MDS/MPS.
- Review the outcome of patients with rare congenital anemias and cytopenias who may subsequently develop MDS as adolescents or adult patients.
General (pediatric) hematologists.
EBAH CME Accreditation
Tutorials are accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of Hematology. Staying abreast of these scientific developments and keeping in touch with the up-to-date views on clinical policy will enable you to raise your professional level, ultimately resulting in the best treatment for your patients.